litlas
Log inCreate account

Edward M. Messing

Active 1978–2025

103
Papers
18,192
Citations
77
h-index
102
i10-index

Citations

Citations per year for Edward M. Messing1931: 1 citations1953: 1 citations1978: 1 citations1982: 1 citations1984: 1 citations1985: 2 citations1987: 6 citations1988: 2 citations1989: 5 citations1990: 17 citations1991: 2 citations1992: 8 citations1993: 8 citations1994: 14 citations1995: 20 citations1996: 12 citations1997: 38 citations1998: 38 citations1999: 32 citations2000: 42 citations2001: 51 citations2002: 52 citations2003: 76 citations2004: 102 citations2005: 102 citations2006: 119 citations2007: 117 citations2008: 138 citations2009: 159 citations2010: 145 citations2011: 125 citations2012: 129 citations2013: 180 citations2014: 134 citations2015: 118 citations2016: 92 citations2017: 86 citations2018: 104 citations2019: 389 citations2020: 339 citations2021: 283 citations2022: 211 citations2023: 148 citations2024: 248 citations2025: 91 citations2026: 4 citations1932–1952: no citations, so these years are not shown1954–1977: no citations, so these years are not shown1979–1981: no citations, so these years are not shown1983: no citations, so this year is not shown1986: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,777 citing papers, 31.4% of this breakdownChina: 414 citing papers, 7.3% of this breakdownCanada: 313 citing papers, 5.5% of this breakdownUnited Kingdom: 307 citing papers, 5.4% of this breakdownItaly: 305 citing papers, 5.4% of this breakdownGermany: 301 citing papers, 5.3% of this breakdownFrance: 217 citing papers, 3.8% of this breakdownNetherlands: 180 citing papers, 3.2% of this breakdownJapan: 148 citing papers, 2.6% of this breakdownSpain: 143 citing papers, 2.5% of this breakdownBelgium: 115 citing papers, 2% of this breakdownAustria: 113 citing papers, 2% of this breakdown
0%31.4%Other 23.6%

Institutions

Fields

  • Medicine75%
  • Biochemistry, Genetics and Molecular Biology16%
  • Engineering3.5%
  • Immunology and Microbiology1.5%
  • Computer Science0.9%
  • Physics and Astronomy0.5%
  • Other2.6%

Topics

  • Bladder and Urothelial Cancer Treatments9.1%
  • Prostate Cancer Treatment and Research8.6%
  • Prostate Cancer Diagnosis and Treatment7.5%
  • Urinary and Genital Oncology Studies4.5%
  • Urinary Bladder and Prostate Research3.1%
  • Renal cell carcinoma treatment2.7%
  • Other64.5%

Coauthors

All papers

Open in search
  1. Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer on Tumor Recurrence

    Authors: Edward M. Messing, Catherine M. Tangen, Seth P. Lerner, Deepak M. Sahasrabudhe, Theresa M. Koppie, David P. Wood, Philip C. Mack, Robert S. Svatek, Christopher P. Evans, Khaled S. Hafez, Daniel J. Culkin, Timothy C. Brand, Lawrence I. Karsh, Jeffrey M. Holzbeierlein, Shandra Wilson, Guan Wu, Melissa Plets, Nicholas J. Vogelzang, Ian M. Thompson - JAMA 2018 cited by 237

  2. Renal Function After Nephron-sparing Surgery Versus Radical Nephrectomy: Results from EORTC Randomized Trial 30904

    Authors: Emil Scosyrev, Edward M. Messing, Richard Sylvester, Steven C. Campbell, Hendrik Van Poppel - European Urology 2013 cited by 536

  3. The androgen receptor in bladder cancer

    Authors: Jinbo Chen, Chi‐Ping Huang, Chao Quan, Xiongbing Zu, Zhenyu Ou, Yu‐Chieh Tsai, Edward M. Messing, Shuyuan Yeh, Chawnshang Chang - Nature Reviews Urology 2023 cited by 47

  4. Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation

    Authors: Andres Correa, Opeyemi A. Jegede, Naomi B. Haas, Keith T. Flaherty, Michael R. Pins, Edward M. Messing, Judith Manola, Christopher G. Wood, Christopher J. Kane, Michael A.S. Jewett, Janice P. Dutcher, Robert S. DiPaola, Michael A. Carducci, Robert G. Uzzo - Journal of Clinical Oncology 2019 cited by 153

  5. Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study

    Authors: Mark D. Tyson, David Morris, Juan Palou, Óscar Rodríguez, Maria Carmen Mir, Rian J. Dickstein, Félix Guerrero‐Ramos, Kristen R. Scarpato, Jason Hafron, Edward M. Messing, Christopher J. Cutie, John Maffeo, Bradley Raybold, Albert Chau, Katharine A. Stromberg, Kirk A. Keegan - The Journal of Urology 2023 cited by 35

  6. Bladder Cancer Exosomes Contain EDIL-3/Del1 and Facilitate Cancer Progression

    Authors: Carla Beckham, Jayme Olsen, Peng-Nien Yin, Chia-Hao Wu, Huei‐Ju Ting, Fred K. Hagen, Emelian Scosyrev, Edward M. Messing, Yi‐Fen Lee - The Journal of Urology 2014 cited by 209

  7. A Pilot Clinical Trial of Oral Pentosan Polysulfate And Oral Hydroxyzine in Patients With Interstitial Cystitis

    Authors: Grannum R. Sant, Kathleen J. Propert, Philip M. Hanno, David Burks, Daniel J. Culkin, Ananias C. Diokno, Cynthia Hardy, J. Richard Landis, R. Mayer, Rosemary Madigan, Edward M. Messing, Kenneth M. Peters, Theoharis C. Theoharides, Jonathan R. Warren, Alan J. Wein, William D. Steers, John W. Kusek, Leroy M. Nyberg - The Journal of Urology 2003 cited by 279

  8. Localization of androgen receptor expression in human bone marrow

    Authors: Athanasios Mantalaris, Nicki Panoskaltsis, Yasuyuki Sakai, Patricia Bourne, Chawnshang Chang, Edward M. Messing, Jiangbin Wu - The Journal of Pathology 2001 cited by 149

  9. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

    Authors: Edward M. Messing, Judith Manola, Jorge L. Yao, Maureen Kiernan, David Crawford, George Wilding, P. Anthony diSant’Agnese, Donald L. Trump - The Lancet Oncology 2006 cited by 905

  10. Promotion of Bladder Cancer Development and Progression by Androgen Receptor Signals

    Authors: Hiroshi Miyamoto, Zhi Yang, Yei‐Tsung Chen, Hitoshi Ishiguro, Hirotsugu Uemura, Y. Kubota, Yoji Nagashima, Yu‐Jia Chang, Yueh‐Chiang Hu, Μ. Y. Tsai, Shuyuan Yeh, Edward M. Messing, Chawnshang Chang - JNCI Journal of the National Cancer Institute 2007 cited by 404

  11. Sex and racial differences in bladder cancer presentation and mortality in the US

    Authors: Emil Scosyrev, Katia Noyes, Changyong Feng, Edward M. Messing - Cancer 2008 cited by 308

  12. VHL protein‐interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF‐1α

    Authors: Zaibo Li, Dakun Wang, Edward M. Messing, Guan Wu - EMBO Reports 2005 cited by 195

  13. Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling

    Authors: Jinbo Chen, Fu-Ju Chou, Shuyuan Yeh, Zhenyu Ou, Chih‐Rong Shyr, Chi‐Ping Huang, Zhendong Xiang, Yin Sun, Edward M. Messing, Xiongbing Zu, Chawnshang Chang - Oncogene 2019 cited by 43

  14. A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients

    Authors: Edward M. Messing, Jason Gee, Daniel R. Saltzstein, KyungMann Kim, Anthony diSant'Agnese, Jill Kolesar, Linda S. Harris, Adrienne Faerber, Thomas C. Havighurst, Jay M. Young, Mitchell Efros, Robert H. Getzenberg, Marcia A. Wheeler, Joseph A. Tangrea, Howard L. Parnes, Margaret G. House, J. Erik Busby, Raymond J. Hohl, Howard H. Bailey - Cancer Prevention Research 2012 cited by 93

  15. Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma

    Authors: Andres Correa, Opeyemi A. Jegede, Naomi B. Haas, Keith T. Flaherty, Michael R. Pins, Adebowale Adeniran, Edward M. Messing, Judith Manola, Christopher G. Wood, Christopher J. Kane, Michael A.S. Jewett, Janice P. Dutcher, Robert S. DiPaola, Michael A. Carducci, Robert G. Uzzo - European Urology 2021 cited by 67

  16. TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients

    Authors: Nerymar Ortiz-Otero, Jocelyn R. Marshall, Antonio Glenn, Jubin Matloubieh, Jean Joseph, Deepak M. Sahasrabudhe, Edward M. Messing, Michael R. King - BMC Cancer 2021 cited by 22

  17. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder

    Authors: Hiroshi Miyamoto, Jorge L. Yao, Alcides Chaux, Yichun Zheng, Iawen Hsu, Koji Izumi, Chawnshang Chang, Edward M. Messing, George J. Netto, Shuyuan Yeh - British Journal of Urology 2012 cited by 226

  18. Smoking and Bladder Cancer: A Systematic Review of Risk and Outcomes

    Authors: Michael Rink, Joseph J. Crivelli, Shahrokh F. Shariat, Felix K.‐H. Chun, Edward M. Messing, Mark S. Soloway - European Urology Focus 2015 cited by 116

  19. Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

    Authors: Ian M. Thompson, Catherine M. Tangen, Jorge C. Paradelo, M. Scott Lucia, Gary J. Miller, Dean A. Troyer, Edward M. Messing, Jeffrey D. Forman, Joseph L. Chin, Gregory P. Swanson, Edith Canby‐Hagino, E. David Crawford - The Journal of Urology 2009 cited by 1,228

  20. Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer

    Authors: Ian M. Thompson, Catherine M. Tangen, Jorge C. Paradelo, M. Scott Lucia, Gary J. Miller, Dean A. Troyer, Edward M. Messing, Jeffrey D. Forman, Joseph L. Chin, Gregory P. Swanson, Edith Canby‐Hagino, E. David Crawford - JAMA 2006 cited by 898

  21. Androgen receptor is a tumor suppressor and proliferator in prostate cancer

    Authors: Yuanjie Niu, Saleh Altuwaijri, Kuo‐Pao Lai, Chun‐Te Wu, William A. Ricke, Edward M. Messing, Jorge L. Yao, Shuyuan Yeh, Chawnshang Chang - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 257

  22. Prostate cancer in the elderly

    Authors: Emil Scosyrev, Edward M. Messing, Supriya G. Mohile, Dragan Golijanin, Guan Wu - Cancer 2011 cited by 177

  23. Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline

    Authors: Rodney Davis, J. Stephen Jones, Daniel A. Barocas, Erik P. Castle, Erich K. Lang, Raymond J. Leveillee, Edward M. Messing, Scott D. Miller, Andrew C. Peterson, Thomas Türk, William F. Weitzel - The Journal of Urology 2012 cited by 483

  24. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

    Authors: Vinata B. Lokeshwar, Tomonori Habuchi, H. Barton Grossman, William M. Murphy, S. Hautmann, George P. Hemstreet, Aldo Bono, Robert H. Getzenberg, Peter J. Goebell, Bernd J. Schmitz‐Dräger, Jack A. Schalken, Yves Fradet, Michael Marberger, Edward M. Messing, Michael J. Droller - Urology 2005 cited by 431